logo
Argentines reel from health care cutbacks as President Milei's state overhaul mirrors Trump's

Argentines reel from health care cutbacks as President Milei's state overhaul mirrors Trump's

Associated Press8 hours ago

BUENOS AIRES, Argentina (AP) — To outsiders, the Facebook group chat reads like a snarl of nonsensical emojis and letters. To uninsured Argentine cancer patients, it's a lifeline.
The surreptitious network connects advocates who have spare drugs to Argentines with cancer who lost access to their treatment in March 2024 when President Javier Milei suspended a federal agency, known as DADSE, that paid for their expensive medications.
Whenever Facebook cracks the coded pleas and removes the group for violating its rules on drug sales, another appears, swelling with Argentines who say they've grown sicker since the radical libertarian president took a chainsaw to health care.
'All I need for my body to function is this medication, and Milei is saying, 'There's no money,'' said Ariel Wagener, a 47-year-old pizza chef with leukemia who was hospitalized this year with failing kidneys after losing access to his medication. Without DADSE, a month's worth of his leukemia drug costs $21,000.
Wagener's condition stabilized after he got leftover medication via Facebook, donated by a family whose loved one had died of cancer.
The halting of millions of dollars of free cancer drugs is just one way Milei's austerity drive has torn through the public health system that once set Argentina apart in Latin America, ensuring that health care was free for pretty much everyone who couldn't afford private insurance.
Since taking office in December 2023, Milei has slashed Argentina's health care budget by 48% in real terms. His administration fired over 2,000 Health Ministry employees, including 1,400 over just a few days in January.
As part of Milei's plan to remake Argentina's troubled economy and cut waste and bureaucracy, officials gutted the National Cancer Institute, suspending early detection programs for breast and cervical cancer.
They froze federal funds for immunization campaigns, hobbling vaccine access as Argentina confronts a measles outbreak for the first time in decades. They dismantled the National Directorate for HIV, Hepatitis and Tuberculosis, leading to testing and treatment delays. They defunded emergency contraception and stopped distributing abortion pills.
'We're seeing setbacks we haven't seen in decades,' said María Fernanda Boriotti, president of Argentina's Federation of Health Professionals. 'HIV patients without treatment, cancer patients dying for lack of medication, hospitals without resources, health professionals pushed out of the system.'
The government curtailed medical coverage for retirees and lifted price controls on prescription medication and private health plans, causing prices to spike by 250% and 118% respectively, official data shows.
'We've stopped buying milk, yogurt, anything that's not absolutely essential,' said Susana Pecora, 71, who lost the insurance plan that covered her husband's antipsychotic drugs when the price jumped 40% last year.
Milei and Trump see eye-to-eye
Milei campaigned on a promise to shrink the state two years before President Donald Trump and Elon Musk took up their own chainsaws.
The Argentine has become a close ally of the Trump administration, including on health policy. Argentina has followed the U.S. out of the World Health Organization, and last month received a visit from U.S. Secretary of Health and Human Services Robert F. Kennedy Jr.
Meeting Kennedy in Buenos Aires, Argentine Health Minister Mario Lugones announced a review of Argentina's health system to align it with Kennedy's Make America Healthy Again movement.
'We have similar visions about the path forward,' Lugones said of Kennedy.
Milei has not yet attempted to replace universal coverage with an insurance-based system, as he vowed on the campaign trail.
But in stripping Argentines of coverage and increasing premiums and out-of-pocket expenses, he is moving Argentina closer to the U.S. model, said Macarena Sabin Paz, health team coordinator at Argentina's Center for Legal and Social Studies.
'We are beginning to see the idea ... where if you lose your job, or become seriously ill, you may have to sell your car, whatever you have, to pay for health care,' she said.
Milei's staffing cuts have eviscerated agencies tasked with planning, financing and tracking immunization campaigns, disrupting data collection and jeopardizing the country's respected childhood vaccine program.
The cuts have coincided with a measles outbreak that in April led to Argentina's first measles death in two decades.
'Argentina has been one of the most advanced South American countries and here we see it abandoning public health,' said Dr. Stanley Plotkin, an American physician who helped develop the measles vaccine in the 1960s.
Milei's spokesperson, Manuel Adorni, did not respond to requests for comment. Lugones also did not respond to questions on the impact of policy changes.
A tidal wave of cuts After decades of unbridled spending by left-wing populist governments that brought Argentina infamy for defaulting on its debts, Milei delivered on his campaign promises of taming extreme inflation and notching a fiscal surplus.
But even experts who agree Argentina's health care system needed reform say the cutbacks have been so deep and fast that they've hit like a tidal wave.
'In terms of the destruction of the state, we've never experienced anything like this, not even during the military dictatorship,' said Fabio Nuñez, ex-coordinator of the National Directorate for HIV, Hepatitis and Tuberculosis who was among hundreds fired from the agency.
Charged with leading prevention efforts and treatments for infectious diseases, the agency has lost 40% of its staff and 76% of its annual budget. Hospitals now face shortages of everything from virus testing supplies to medications to condoms.
The cuts have coincided with a surge in sexually transmitted infections. Last year HIV cases spiked by 20% and syphilis by 50%.
'They're avoiding the expense now but will pay for it later as people seek emergency care,' said Cristian Pizzuti, a 31-year-old with HIV who documented 103 cases of patients deprived of their daily antiretroviral pills for weeks at a time last year. Pizzuti said he recently received expired medication and suffered a severe allergic reaction after being switched to a cheaper drug.
Tuberculosis cases also climbed by 25% last year. TB clinics report delays in obtaining test results.
'As people go about their lives, waiting for results, they are spreading the disease to others,' said Dr. Santiago Jimenez, who treats HIV and TB patients in an impoverished Buenos Aires neighborhood. 'It's an epidemiological disaster.'
Hospitals under strainFree public hospitals have become flooded with Argentines who dropped their private insurance due to increased premiums or who lost their job — and with it, their social security plans funded through payroll contributions. Buenos Aires facilities reported a 20%-30% increase in demand in the first quarter of 2025 compared to the same period last year.
The strain was visible at the free public Rodolfo Rossi Hospital in La Plata last month, where crowds jostled in the outpatient clinic and long lines spilled from the pharmacy.
Pharmacists have reported drug shortages as mass layoffs caused administrative chaos and the government froze a program that provided basic medications to Argentine public health centers.
Silvana Mansilla, 43, spent half the day waiting to pick up her monthly supply of thyroid medication — which has doubled in price to $22 — only to find the hospital had run out. 'Where's the government? What are they doing about this?' she asked.
With hiring frozen, doctors said they're handling double the patient load.
Overwhelmed by ever-increasing workloads, Argentina's leading public Garrahan Pediatric Hospital in Buenos Aires has hemorrhaged 200 medical professionals since Milei took office.
As annual inflation neared 200% last fall, their salaries lost half of their purchasing power. Doctors left for jobs abroad or better-paying work in private clinics. None were replaced. Medical residents ran a weeklong strike in May, displaying their pay slips for a month of 70-hour work weeks: $700.
Waiting for treatment A lawsuit filed by patient advocacy groups said more than 60 cancer patients have died due to the government's suspension of the DADSE medication program, and over 1,500 patients were waiting for their drugs.
A federal judge ordered the government to reinstate the drug deliveries, but it appealed, arguing that DADSE no longer exists. It said it had created a new, more efficient program to fulfill outstanding requests. But the timeline varies and sometimes the drugs don't come at all.
Timing was everything for patients like Alexis Almirón.
His medical records show the government drug bank received his request for an expensive medication to shrink his malignant tumor on Dec. 11, 2023, the day after Milei's inauguration. His doctor told the agency immediate treatment was urgently needed for the aggressive cancer.
Months passed. His mother, Claudia Caballero, bombarded DADSE with desperate calls asking what was taking so long as Almirón's lymphoma spread from his neck to his brain and stomach. He vomited blood. He lost his eyesight. Caballero tried to crowd-source the $20,000 for a month's supply of the drug but couldn't raise enough.
On March 12 last year, Almirón died at 22.
'They didn't give him the chance to choose to live,' Caballero said, her voice breaking.
The day after she buried her son, Caballero received a call from the Health Ministry. They had good news, the caller said: Her son's medication had finally arrived.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Pimco and King Street's AmSurg Windfall Caps Ugly Distressed-Debt Saga
Pimco and King Street's AmSurg Windfall Caps Ugly Distressed-Debt Saga

Bloomberg

time11 minutes ago

  • Bloomberg

Pimco and King Street's AmSurg Windfall Caps Ugly Distressed-Debt Saga

The sale of AmSurg, an ambulatory surgery company once part of KKR & Co.-backed Envision Healthcare Corp., caps an epic distressed-debt saga that will hand a windfall to investors that took ownership of the business after an ugly debt brawl. Pacific Investment Management Co., King Street Capital Management, and Partners Group are among the AmSurg owners netting nearly $4 billion from the deal to sell the company to Ascension Health, one of the biggest nonprofit health systems in the US.

Tiotropium Use in COPD Linked to Minimal Risk for Dementia
Tiotropium Use in COPD Linked to Minimal Risk for Dementia

Medscape

time25 minutes ago

  • Medscape

Tiotropium Use in COPD Linked to Minimal Risk for Dementia

The initiation of tiotropium monotherapy was associated with, at most, a modest increase in dementia risk among older adults with chronic obstructive pulmonary disease (COPD) compared with long-acting beta 2-agonist combined with inhaled corticosteroid (LABA-ICS) over a long-term follow-up, although the clinical significance of this finding remains uncertain. METHODOLOGY: Researchers conducted a population-based cohort study using administrative data from Ontario, Canada, to examine whether the initiation of tiotropium monotherapy affects the risk for dementia in older adults with COPD. They included 30,960 new users of tiotropium monotherapy and compared them with 19,530 new users of LABA-ICS (mean age, 75.1 years; 46.7% women), all of whom had COPD without dementia and had started the medication from September 2004 through February 2012. The participants were followed up for a median of 7.59 years from the time of cohort entry. The study endpoint was incident dementia or censoring (death, insurance termination, or 10-year follow-up), whichever happened first. TAKEAWAY: Compared with the initiation of LABA-ICS, tiotropium monotherapy was associated with a 9% higher risk for dementia (hazard ratio [HR], 1.09; 95% CI, 1.04-1.14). However, in the secondary as-treated analysis, the initiation of tiotropium was not associated with an increased risk for dementia compared with LABA-ICS (HR, 1.11; 95% CI, 0.93-1.32). Subgroup analysis revealed an 18% higher risk for dementia with tiotropium monotherapy vs LABA-ICS in adults younger than 75 years and a 12% higher risk in men. IN PRACTICE: 'On balance, this evidence does not provide a compelling argument that patients with COPD should avoid tiotropium due to concerns about cognitive decline,' the authors of the study wrote. SOURCE: This study was led by Che-Yuan Wu, University of Toronto, Toronto, Ontario, Canada. It was published online on May 19, 2025, in JAMA Internal Medicine. LIMITATIONS: This study was potentially confounded by unmeasured factors such as smoking, dyspnea, peripheral biomarkers, spirometry measures, and other anticholinergic drugs. The assumption that the LABA-ICS comparator had no effect on the risk for dementia might not be true. The data for midlife medication dispensing and dementia biomarkers were unavailable. DISCLOSURES: This study was supported by the Heart-Brain Connection Brain-Heart Research Integrative Innovation Team Endeavor IMPACT Award from the Heart and Stroke Foundation of Canada, Brain Canada, and other sources. Few authors reported receiving financial support and grants from study funders and other sources.

Catherine, Princess of Wales, Unexpectedly Pulls Out of Royal Ascot
Catherine, Princess of Wales, Unexpectedly Pulls Out of Royal Ascot

New York Times

time29 minutes ago

  • New York Times

Catherine, Princess of Wales, Unexpectedly Pulls Out of Royal Ascot

Catherine, the Princess of Wales and wife of Prince William, canceled plans on Wednesday to attend the horse races at Royal Ascot, a last-minute withdrawal that raised questions about the state of her recovery from cancer. Kensington Palace, where Catherine and William have their offices, confirmed that William would attend the races, a popular date on the calendar of royals, but would not be joined by Catherine, who has appeared more regularly in public since announcing last September that she had completed chemotherapy treatment for an undisclosed type of cancer. In January, Catherine said she was in remission. The princess is 'disappointed' not to be present, said a palace official, who spoke on condition of anonymity, citing palace protocol. He added that she needs to find the 'right balance' when returning to public engagements. On Saturday, Catherine took part in Trooping the Color, a ceremony that marks the birthday of the monarch, King Charles III. Her public appearances had become routine, though her schedule is not as busy as it was before her illness. This is a developing story. Please check back for updates.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store